Hematologic and musculoskeletal disorders segment
Keros Therapeutics, Inc. - common stock
Hematologic and musculoskeletal disorders
Last highlighted: #KROS SEC report: Keros Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Keros Therapeutics, Inc. -- SEC File Number 211148197
+ My List
We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.